We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Shionogi Sues To Block Another Generic Fortamet Challenge

Law360, New York (July 17, 2012, 3:23 PM EDT) -- Japanese pharmaceutical company Shionogi Inc. launched its latest bid to defend its Type 2 diabetes treatment Fortamet on Friday, suing Nostrum Pharmaceuticals LLC over its effort to market a generic version...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.